The emergence of novel respiratory infections (eg, COVID-19) and expeditious development
of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in …

Introduction Drugs delivered via the lungs are predominantly used to treat various
respiratory disorders, including asthma, chronic obstructive pulmonary diseases, respiratory …

Radiation therapy is an effective method to kill cancer cells and shrink tumors using high-
energy X-ray or γ-ray. Radiation pneumonitis (RP) is one of the most serious complications …

Non-small cell lung cancer (NSCLC) is a global concern as one of the leading causes of
cancer deaths. The treatment options for NSCLC are limited to systemic chemotherapy …

Abstract Copper oxide nanoparticles (CuO NPs) can adversely affect lung health possibly by
inducing oxidative damage through the release of copper ions. However, the migration and …

The interaction of hydrophobic silicon dioxide particles (fumed silicon dioxide), as model air
pollutants, and Langmuir monolayers of a porcine lung surfactant extract has been studied …

Optimization of the in vivo performance of dosage forms in humans is essential in
developing not only conventional formulations but also drug delivery system (DDS) …

In vitro-in vivo correlation is the establishment of a predictive relationship between in vitro
and in vivo data. In the context of cascade impactor results of orally inhaled pharmaceutical …

Pollution is currently a public health problem associated with different cardiovascular and
respiratory diseases. These are commonly originated as a result of the pollutant transport to …

Dry powder inhalers (DPIs) are regularly used to treat respiratory diseases. Adding extrinsic
fine excipient particles to the blend of active pharmaceutical ingredient (API) and carrier is …